Jane Street Group, LLC Abbott Laboratories Call Options Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

Call Options

20 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $40.1 Million - $47.3 Million	400,400 New	400,400 $45.6 Million
Q1 2022 May 17, 2022	BUY	$114.02 - $139.04 $18 Million - $21.9 Million	157,600 Added 17.92%	1,037,000 $123 Million
Q4 2021 Feb 15, 2022	BUY	$115.53 - $141.46 $16.9 Million - $20.7 Million	146,000 Added 19.91%	879,400 $124 Million
Q3 2021 Nov 16, 2021	BUY	$116.66 - $129.06 $35 Million - $38.8 Million	300,300 Added 69.34%	733,400 $86.6 Million
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $3.48 Million - $4.1 Million	32,900 Added 8.22%	433,100 $50.2 Million
Q1 2021 May 18, 2021	SELL	$108.84 - $128.23 $20.9 Million - $24.7 Million	-192,300 Reduced 32.46%	400,200 $48 Million
Q4 2020 Feb 17, 2021	BUY	$105.0 - $114.42 $210,000 - $228,840	2,000 Added 0.34%	592,500 $64.9 Million
Q3 2020 Nov 17, 2020	SELL	$91.64 - $111.29 $10.3 Million - $12.5 Million	-112,000 Reduced 15.94%	590,500 $64.3 Million
Q2 2020 Aug 17, 2020	SELL	$76.57 - $98.0 $39.6 Million - $50.7 Million	-516,900 Reduced 42.39%	702,500 $64.2 Million
Q1 2020 May 15, 2020	BUY	$62.82 - $91.86 $67.4 Million - $98.5 Million	1,072,200 Added 728.4%	1,219,400 $96.2 Million
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $7.47 Million - $8.31 Million	95,100 Added 182.53%	147,200 $12.8 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $7.38 Million - $8 Million	-90,200 Reduced 63.39%	52,100 $4.36 Million
Q2 2019 Aug 15, 2019	BUY	$72.88 - $85.0 $4.18 Million - $4.87 Million	57,300 Added 67.41%	142,300 $12 Million
Q1 2019 May 16, 2019	SELL	$66.22 - $80.06 $3.4 Million - $4.12 Million	-51,400 Reduced 37.68%	85,000 $6.8 Million
Q4 2018 Feb 15, 2019	SELL	$65.56 - $74.27 $3.07 Million - $3.48 Million	-46,800 Reduced 25.55%	136,400 $9.87 Million
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $9.52 Million - $11.5 Million	156,600 Added 588.72%	183,200 $13.4 Million
Q2 2018 Aug 15, 2018	SELL	$57.57 - $63.54 $362,691 - $400,302	-6,300 Reduced 19.15%	26,600 $1.62 Million
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $602,089 - $680,734	10,700 Added 48.2%	32,900 $1.97 Million
Q4 2017 Feb 15, 2018	SELL	$53.68 - $57.47 $1.81 Million - $1.94 Million	-33,700 Reduced 60.29%	22,200 $1.27 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $2.69 Million - $3 Million	55,900	55,900 $2.98 Million

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.6 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15.3 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$8.96 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.68 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.23 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account